Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects
Open Access
- 11 May 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 6, 139
Abstract
Currently, schizophrenia is considered a multifactorial disease. Over the past 50 years, many investigators have considered the role of toxic free radicals in the etiology of schizophrenia. This is an area of active research which is still evolving. Here, we review the recent data and current concepts on the roles of nitric oxide (NO) and related molecules in the pathogenesis of schizophrenia. NO is involved in storage, uptake and release of mediators and neurotransmitters, including glutamate, acetylcholine, noradrenaline, GABA, taurine and glycine. In addition, NO diffuses across cell membranes and activates its own extrasynaptic receptors. Further, NO is involved in peroxidation and reactive oxidative stress. Investigations reveal significant disturbances in NO levels in the brain structures (cerebellum, hypothalamus, hippocampus, striatum) and fluids of subjects with schizophrenia. Given the roles of NO in central nervous system development, these changes may result in neurodevelopmental changes associated with schizophrenia. We describe here the recent literature on NOS gene polymorphisms on schizophrenia, which all point to consistent results. We also discuss how NO may be a new target for the therapy of mental disorders. Currently there have been 2 randomized double-blind placebo-controlled trials of L-lysine as an NOS inhibitor in the CNS.Keywords
This publication has 215 references indexed in Scilit:
- Meta-Analysis of Oxidative Stress in SchizophreniaBiological Psychiatry, 2013
- Oxidative stress in schizophrenia: An integrated approachNeuroscience & Biobehavioral Reviews, 2011
- White matter neuron alterations in schizophrenia and related disordersInternational Journal of Developmental Neuroscience, 2010
- Impact of dopamine–glutamate interactions on striatal neuronal nitric oxide synthase activityPsychopharmacology, 2009
- The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patientsSchizophrenia Research, 2009
- Reduced neuronal nitric oxide synthase is involved in ischemia‐induced hippocampal neurogenesis by up‐regulating inducible nitric oxide synthase expressionJournal of Neurochemistry, 2007
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Increased Expression in Dorsolateral Prefrontal Cortex of CAPON in Schizophrenia and Bipolar DisorderPLOS Medicine, 2005
- Genetic Classification of Primary Neurodegenerative DiseaseScience, 1998
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980